Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.56761 | 23 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.54286 | 23 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.5457 | 23 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.51037 | 24 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.50554 | 24 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.61641 | 24 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.54169 | 22 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.52625 | 23 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.51152 | 23 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.53705 | 24 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.52776 | 23 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.50681 | 23 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.53536 | 23 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.5368 | 23 |